JUDITH BELL: Open Payments
NPI 1699107011 · BUFFALO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,202 in 11 payments from 7 companies in 2025. Trend: 2023 $371 · 2024 $1,310 · 2025 $1,202
Food & beverage: $1,202
| Company | Payments | Amount |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | 3 | $346 |
| Alnylam Pharmaceuticals Inc. | 2 | $272 |
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| Teva Pharmaceuticals USA, Inc. | 1 | $125 |
| SK Life Science, Inc. | 2 | $125 |
| Alexion Pharmaceuticals, Inc. | 1 | $112 |
| Neurocrine BioSciences, Inc. | 1 | $97 |
Products named: VOQUEZNA, AMVUTTRA, WAINUA, AUSTEDO XR, ULTOMIRIS, XCOPRI, INGREZZA.
Industry payments across NY — which companies pay providers there.
